Hide metadata

dc.date.accessioned2023-01-17T16:26:01Z
dc.date.available2023-01-17T16:26:01Z
dc.date.created2022-05-31T21:56:43Z
dc.date.issued2022
dc.identifier.citationVandraas, Kathrine Flørenes Falk, Ragnhild Sørum Bøhn, Synne-Kristin Hoffart Kiserud, Cecilie E. Lie, Hanne Cathrine Smedsland, Solveig Katrine Ewertz, Marianne Dahl, Sigrun Brekke, Mette Reinertsen, Kristin Valborg . Work ability 8 years after breast cancer: exploring the role of social support in a nation-wide survey. Breast Cancer Research and Treatment. 2022, 193, 685-694
dc.identifier.urihttp://hdl.handle.net/10852/98861
dc.description.abstractAbstract Introduction As the 5-year survival rate after breast cancer in Norway is 92%, the population of breast cancer survivors (BCSs) is increasing. Knowledge of work ability in this population is scarce. In a population-based cohort of BCSs, we explored work ability 8 years after diagnosis and the association between work ability and social support, and cancer-related variables including late effects and lifestyle factors. Methods In 2019, all Norwegian women < 59 years when diagnosed with stage I–III breast cancer in 2011 or 2012, were identified by the Cancer Registry of Norway and invited to participate in a survey on work life experiences. Work ability was assessed using the Work Ability Index (scale 0–10). Factors associated with excellent work ability (score ≥ 9) were identified using univariate and multivariate logistic regression analyses, and adjusted for socioeconomic-, health- and cancer-related variables. Results Of the 1951 eligible BCSs, 1007 (52.8%) responded. After excluding survivors with relapse ( n  = 1), missing information on work ability score ( n  = 49), or work status ( n  = 31), the final sample comprised 926 BCSs within working age at survey (< 67 years). Mean age at survey was 56 years and 8 years (SD 0.7) had passed since diagnosis. Work ability had been reduced from 8.9 (SD 2.3) at diagnosis to 6.3 (SD 3.1). One in three BCSs reported poor work ability (WAS ≤ 5), and seven out of ten reported that their physical work ability had been reduced due to cancer. Social support from colleagues during cancer therapy was associated with excellent work ability, which was not observed for social support provided by supervisors or the general practitioner. Cognitive impairment and fatigue were inversely associated with work ability. None of the cancer-related variables, including treatment, were associated with work ability 8 years after diagnosis. Conclusion In this population-based sample, one in three BCSs reported poor work ability 8 years after diagnosis. Collegial social support during cancer therapy appears to be a protective factor for sustained work ability, whilst survivors struggling with fatigue and cognitive impairments may represent a particularly vulnerable group for reduced work ability.
dc.languageEN
dc.publisherKluwer Academic/Plenum Publishers
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleWork ability 8 years after breast cancer: exploring the role of social support in a nation-wide survey
dc.title.alternativeENEngelskEnglishWork ability 8 years after breast cancer: exploring the role of social support in a nation-wide survey
dc.typeJournal article
dc.creator.authorVandraas, Kathrine Flørenes
dc.creator.authorFalk, Ragnhild Sørum
dc.creator.authorBøhn, Synne-Kristin Hoffart
dc.creator.authorKiserud, Cecilie E.
dc.creator.authorLie, Hanne Cathrine
dc.creator.authorSmedsland, Solveig Katrine
dc.creator.authorEwertz, Marianne
dc.creator.authorDahl, Sigrun
dc.creator.authorBrekke, Mette
dc.creator.authorReinertsen, Kristin Valborg
cristin.unitcode185,51,0,0
cristin.unitnameInstitutt for medisinske basalfag
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin2028614
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Breast Cancer Research and Treatment&rft.volume=193&rft.spage=685&rft.date=2022
dc.identifier.jtitleBreast Cancer Research and Treatment
dc.identifier.volume193
dc.identifier.issue3
dc.identifier.startpage685
dc.identifier.endpage694
dc.identifier.doihttps://doi.org/10.1007/s10549-022-06599-z
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn0167-6806
dc.type.versionPublishedVersion
dc.relation.projectKF/197255


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International